Trade Therapy: Deepening Cooperation to Strengthen Pandemic Defenses
Box 3.4
Health technology transfer to least developed countries (Continued)
Figure B3.4.2 Types of health technology transfer programs reported by WTO developed country members under TRIPS Agreement, art. 66.2, 2018–20
Infe ct dise ious ase
s Diabete
Child heal th
Reproduc... maternal and health
s
ce
rvi
HI
ria
Mala
le
icab mun Com eases dis
TB
pm
en t
ra
Health care system
ui
Pa an rasit ic dv dis ecto eas r e CO VI D19
. r.. i.. to ag ira rh sp or Re m al... e l h rrhe a Di
Vi
Hea lth syste care serv m, ices, a equ nd ipm ent
nal Mater d il h c and health
Se
V
Non... y or lat s, gu ard .. Re nd an. sta ety f sa
pr he odu alt c... h
n... ty a Safe
ry to la rds gu da Re tan s
Re
Eq
126
Source: World Trade Organization (WTO) calculations based on the reports (required under WTO TRIPS Agreement, art. 66.2) submitted by WTO developed country members. Note: The figure indicates relative shares of the number of programs, by program focus. “Developed country members” of the WTO include Australia, Canada, the European Union (and its member states), Japan, New Zealand, Norway, Switzerland, the United Kingdom, and the United States. TB = tuberculosis; TRIPS = Trade-Related Aspects of Intellectual Property Rights.
States provided 72 percent of those programs. Uganda and Tanzania were among the top-ranking beneficiaries, each benefiting from at least 30 health technology transfer programs. Around 42 percent of the reported health technology transfer programs have a particular focus on communicable diseases such as HIV, malaria, and tuberculosis (figure B3.4.2). (Continued)
